Valuation: Vetoquinol SA

Capitalization 88Cr 103.16Cr 80Cr 76Cr 141.21Cr 9.74TCr 142.46Cr 951.43Cr 370.89Cr 4.68TCr 387.01Cr 378.87Cr 16TCr P/E ratio 2025
16.9x
P/E ratio 2026 * 15.7x
Enterprise value 66Cr 77Cr 60Cr 57Cr 105.66Cr 7.29TCr 106.59Cr 711.88Cr 277.51Cr 3.5TCr 289.57Cr 283.48Cr 12TCr EV / Sales 2025
1.48x
EV / Sales 2026 * 1.16x
Free-Float
32.03%
Yield 2025
1.11%
Yield 2026 * 1.24%
1 day-1.08%
1 week-1.21%
Current month-4.55%
1 month-7.55%
3 months-15.61%
6 months+1.94%
Current year-11.98%
1 week 72.9
Extreme 72.9
77
1 month 72.9
Extreme 72.9
84.9
Current year 72.9
Extreme 72.9
91.5
1 year 68.7
Extreme 68.7
91.5
3 years 63.6
Extreme 63.6
110
5 years 63.6
Extreme 63.6
161
10 years 35.42
Extreme 35.42
161
Manager TitleAgeSince
Chief Executive Officer 57 22/09/2010
Director of Finance/CFO 61 01/12/2010
Chief Tech/Sci/R&D Officer - 01/03/2021
Director TitleAgeSince
Director/Board Member 85 22/09/2009
Chairman 88 01/01/1980
Chairman 57 01/07/2023
Change 5d. change 1-year change 3-years change Capi.($)
-1.08%-1.21%+0.82%-21.14% 103.16Cr
-5.13%-27.44%-47.99%-55.26% 3.47TCr
-1.50%+5.06%+97.74%+162.78% 1.18TCr
-2.54%-7.45%+25.51%+50.92% 557.04Cr
-2.47%-1.93%+15.99%+17.13% 359.43Cr
+1.48%+3.43%+116.19%+40.11% 242.47Cr
-0.82%-2.25%-21.57%-10.32% 175.88Cr
-7.32%-27.13%+78.02%+184.09% 162.26Cr
+0.28%-0.39%-13.72%-10.57% 119.72Cr
+0.41%-1.99%+8.38%-45.93% 110.67Cr
Average -1.35%-6.36%+25.94%+31.18% 648.43Cr
Weighted average by Cap. -0.75%-15.55%+0.80%+9.89%

Financials

2025 2026 *
Net sales 53Cr 62Cr 48Cr 46Cr 85Cr 5.86TCr 86Cr 572.51Cr 223.18Cr 2.82TCr 232.88Cr 227.98Cr 9.72TCr 52Cr 61Cr 48Cr 45Cr 84Cr 5.8TCr 85Cr 566.46Cr 220.82Cr 2.79TCr 230.42Cr 225.57Cr 9.62TCr
Net income 5.86Cr 6.9Cr 5.36Cr 5.06Cr 9.44Cr 651.41Cr 9.53Cr 64Cr 25Cr 312.9Cr 26Cr 25Cr 1.08TCr 5.6Cr 6.59Cr 5.12Cr 4.83Cr 9.01Cr 621.95Cr 9.09Cr 61Cr 24Cr 298.75Cr 25Cr 24Cr 1.03TCr
Net Debt -22Cr -26Cr -20Cr -19Cr -36Cr -2.45TCr -36Cr -239.55Cr -93Cr -1.18TCr -97Cr -95Cr -4.07TCr -27Cr -32Cr -25Cr -23Cr -44Cr -3.02TCr -44Cr -295.17Cr -115.06Cr -1.45TCr -120.07Cr -117.54Cr -5.01TCr
Logo Vetoquinol SA
Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets (71.6% of net sales; dogs, cats, etc.) and livestock (28.4%; cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families: - antibiotics; - anti-inflammatories; - cardiology and nephrology treatments; - other: anti-parasitics, vaccines, and nutritional products. At the end of 2025, the group had 5 production sites throughout the world. Net sales are distributed geographically as follows: Europe (53.4%), the United States (20.9%), America (14%) and Asia/Pacific (11.7%).
Employees
2,497
Date Price Change Volume
11/26/11 73.50 -1.08% 1,359
08/26/08 74.30 -1.85% 1,283
07/26/07 75.70 -0.53% 1,365
06/26/06 76.10 +2.56% 3,789
05/26/05 74.20 -0.27% 3,555
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
74.30EUR
Average target price
89.30EUR
Spread / Average Target
+20.19%

Quarterly revenue - Rate of surprise